Granted Patent
B2
US 10,016,411 · App. 15/026,579 · Granted Jul 10, 2018
Slow-release conjugates of SN-38
Assignee:
ProLynx LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Conjugates of SN-38 that provide optimal drug release rates and minimize the formation of the corresponding glucuronate are described. The conjugates release SN-38 from a polyethylene glycol through a β-elimination mechanism.
Claims (5)
1. A conjugate having the formula
wherein m =1-6 and n is 200-250.
2. The conjugate of claim 1 wherein m is 1.
3. A pharmaceutical formulation comprising a conjugate of claim 1 together with a pharmaceutically acceptable excipient.
4. The formulation of claim 3 , wherein the pH of the formulation is between 4.0 and 6.0.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 14, 2016
From: ASHLEY, GARY; SCHNEIDER, ERIC L.
To: PROLYNX LLC
Reel/Frame 038907/0257 →
Continuity (2)
Provisional Application
61887111
· Oct 4, 2013
Cited By (1)